Tag: Ajay Bhargava
IP profit v human loss
With covid-19 vaccines rolling out, the question of compulsory licensing weighs up IPR profit and protection against public health and accessProfit v losses
As an elusive covid-19 vaccine draws closer, big pharma is licking its lips at the monetary potential of what could be a virtually limitless ongoing global demand. But governments may use compulsory licensing regulation to tilt the scale towards affordability as the death toll escalatesIP profit v human loss
Big pharma is racing to find covid-19 vaccines in the hope of profiting from a virtually limitless global demand, but governments are likely to step in to tilt the scaleLATEST ON VANTAGE ASIA
Litigate or arbitrate? Flexibilities for foreign disputes in Thailand
By Pisut Attakamol, Baker McKenzie
MOST READ ON VANTAGE ASIA
Investment strategies, regulations and policies in India
By Rishabh Shroff, Cyril Amarchand Mangaldas
Designing a JV contract in Taiwan
By Lee Li-pu, Chen Chiu-hua and Teresa Pan, Formosan Brothers Attorneys-at-Law
Establishing an investment fund in Israel
By Anat Shavit, Ron Lehmann and Ron Sitton, Fischer Behar Chen Well Orion & Co
Outbound investment strategies into the US
By I Bobby Majumder, Lynwood E Reinhardt and Brooke C Dorris,
Compliance challenges for foreign investment in the US
By Jeffrey L Kessler, Eva W Cole and Heather P Lamberg, Winston & Strawn
The top 100 foreign lawyers for India-related matters